GoldBamboo.com - Knowledge is strong medicine
  

The S.A.F.E. Study : Computer-Aided Counseling to Prevent Teen Pregnancy/STDs - Article


  Not Signed In - Sign In / Register






Psychotherapy & Counseling


Clinical Trial: The S.A.F.E. Study : Computer-Aided Counseling to Prevent Teen Pregnancy/STDs

This study is currently recruiting patients.
Verified by University of Pittsburgh September 2005

Sponsors and Collaborators: University of Pittsburgh
National Institute of Child Health and Human Development (NICHD)
Information provided by: University of Pittsburgh
ClinicalTrials.gov Identifier: NCT00151151

Purpose

This is a randomized clinical trial assessing the efficacy of two types of counseling (Computer-Assisted Motivational Intervention (CAMI) versus Didactic Educational Counseling (DEC)) to see which can better reduce female adolescents'''' risk taking behaviors that put them at risk for unintended pregnancy and sexually transmitted diseases (STDs). The intervention phase consists of three 30-minute counseling sessions over the first 6 months followed by a visit every three months during the 12 month follow up phase. We hypothesize that the CAMI will decrease the proportion of subjects who engage in any intercourse that is poorly protected against pregnancy and against STDs.
Condition Intervention
Pregnancy
Sexually Transmitted Diseases
 Behavior: Computer-Assisted Motivational Intervention
 Behavior: Didactic Educational Counseling

MedlinePlus related topics:  Sexually Transmitted Diseases

Study Type: Interventional
Study Design: Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study

Official Title: The S.A.F.E. Study: Computer-Aided Counseling to Prevent Teen Pregnancy/STDs - Validity and Reliability Testing of Computer Measures, Pilot-Testing of Timeline Followback Calendar Protocol, and Randomized Efficacy Study

Further Study Details: 
Primary Outcomes: Self-reported sexual and contraceptive behaviors recorded by a 90-day timeline follow back interview at 9 and 18 months compared to baseline
Secondary Outcomes: Stage of readiness to be abstinent, use condoms, spermicide, and hormonal contraception based on a computerized assessment; reported drug and alcohol use recorded by a 90-day timeline follow back interview
Expected Total Enrollment:  660

Study start: February 2003;  Expected completion: September 2007
Last follow-up: January 2007;  Data entry closure: March 2007

Adolescent unintended pregnancy and STDs remain at epidemic levels in the United States. Healthy People 2010 Objectives set a goal to increase to 90% the proportion of sexually active adolescents who use contraception that both effectively prevents pregnancy and provides barrier protection against disease. How to effectively counsel adolescents to reach this goal is unclear. Counseling and feedback based on the Transtheoretical Model (TTM) have demonstrated greater success than standard, action-oriented advice in several domains of behavior change. The effectiveness of this type of counseling to alter female adolescents'''' sexual and contraceptive behaviors has not been rigorously evaluated. We propose recruiting 660 female adolescents, ages 13 to 21 years, from an inner-city, hospital-based clinic and randomizing them to either an innovative Computer-Assisted Motivational Intervention (CAMI) or a Didactic Educational Control (DEC). The CAMI group will receive three, 30-minute sessions of one-on-one counseling with a counselor that is guided by computer-generated personalized feedback. The CAMI is based on the principles of the TTM and on Motivational Interviewing. The DEC provides three 30-minute sessions of one-on-one didactic information on contraception, STD prevention, and abstinence. The two interventions are identical in length and timing but vary in educational content, counseling style, and the provision of personalized feedback. We will track the two groups of female adolescents in this study through a 6-month intervention phase and a 12-month follow-up phase to assess differences in sexual and contraceptive behaviors by group. The primary specific aim for the study is to evaluate the efficacy of the CAMI as compared to the DEC in reducing sexual behaviors that increase the risks of both unintended pregnancy and STDs. We will examine protective sexual behaviors in three ways: 1) behaviors that protect against pregnancy; 2) behaviors that protect against STDs; and 3) behaviors that protect against both pregnancy and STDs. Our primary hypothesis is that the CAMI will decrease the proportion of subjects who engage in any intercourse that is poorly protected against pregnancy and against STDs. We also predict that among sexually active subjects, the CAMI will increase the percentage of episodes of intercourse that are well protected by the use of both condoms plus another contraceptive. Finally, we also predict that the CAMI will increase the prevalence of abstinence among the entire sample. If proven effective, computer-assisted personalized motivational counseling could be broadly implemented as a method to decrease the incidence of unintended pregnancy and STDs among female adolescents.

Eligibility

Ages Eligible for Study:  13 Years   -   21 Years,  Genders Eligible for Study:  Female

Accepts Healthy Volunteers

Criteria

Inclusion Criteria:

  • Female adolescents, ages 13 to 21 years of age, not currently pregnant or planning pregnancy in next 18 months, English speaking, able to return every 3 months to study office for 18 months

Exclusion Criteria:

  • Medically or surgically sterile, has IUD or subdermal contraceptive implant, hearing or visual impairments that might interfere with using the computerized assessment or participating in counseling session, in foster care or on house arrest, has sex exclusively with female partners

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00151151

Melanie A. Gold, DO      412 -692-8504    magold@pitt.edu
Rita L. Labbett, BA      412-692-6829    Rita.Labbett@chp.edu

Pennsylvania
      Children''''s Hospital of Pittsburgh, Pittsburgh,  Pennsylvania,  15213,  United States; Recruiting
Rita L. Labbett, BA  412-692-6829    Rita.Labbett@chp.edu 
Melanie A. Gold, DO  412-692-8504    magold@pitt.edu 
Melanie A. Gold, DO,  Principal Investigator

Study chairs or principal investigators

Melanie A. Gold, DO,  Principal Investigator,  University of Pittsburgh   

More Information

Study ID Numbers:  0405473; HD41058
Last Updated:  September 7, 2005
Record first received:  September 6, 2005
ClinicalTrials.gov Identifier:  NCT00151151
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2005-09-13


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Psychotherapy & Counseling.

October 7, 2008



Page Updated: June 12, 2007
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Massachusetts Law | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.